Isoniazid (INH) is an irreversible inhibitor of Monoamine oxidase A (MAOA) that is widely regarded as a major anti-tuberculosis drug (Zareifopoulos and Panayiotakopoulos, 2017). The gene discussed is MAOA; the disease is tuberculosis.